Westover Capital Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $245K | Hold |
1,120
| – | – | 0.05% | 203 |
|
|
2025
Q1 | $251K | Hold |
1,120
| – | – | 0.06% | 206 |
|
|
2024
Q4 | $367K | Sell |
1,120
-8
| -0.7% | -$2.62K | 0.08% | 169 |
|
|
2024
Q3 | $339K | Hold |
1,128
| – | – | 0.07% | 189 |
|
|
2024
Q2 | $372K | Sell |
1,128
-132
| -10% | -$43.5K | 0.1% | 158 |
|
|
2024
Q1 | $499K | Sell |
1,260
-140
| -10% | -$55.4K | 0.15% | 112 |
|
|
2023
Q4 | $493K | Hold |
1,400
| – | – | 0.16% | 104 |
|
|
2023
Q3 | $525K | Hold |
1,400
| – | – | 0.19% | 97 |
|
|
2023
Q2 | $535K | Hold |
1,400
| – | – | 0.19% | 98 |
|
|
2023
Q1 | $485K | Hold |
1,400
| – | – | 0.18% | 97 |
|
|
2022
Q4 | $329K | Hold |
1,400
| – | – | 0.13% | 111 |
|
|
2022
Q3 | $345K | Hold |
1,400
| – | – | 0.13% | 109 |
|
|
2022
Q2 | $423K | Hold |
1,400
| – | – | 0.16% | 104 |
|
|
2022
Q1 | $575K | Hold |
1,400
| – | – | 0.18% | 100 |
|
|
2021
Q4 | $657K | Hold |
1,400
| – | – | 0.19% | 95 |
|
|
2021
Q3 | $594K | Hold |
1,400
| – | – | 0.19% | 93 |
|
|
2021
Q2 | $503K | Hold |
1,400
| – | – | 0.16% | 102 |
|
|
2021
Q1 | $394K | Hold |
1,400
| – | – | 0.14% | 113 |
|
|
2020
Q4 | $397K | Hold |
1,400
| – | – | 0.14% | 106 |
|
|
2020
Q3 | $385K | Hold |
1,400
| – | – | 0.16% | 97 |
|
|
2020
Q2 | $318K | Hold |
1,400
| – | – | 0.15% | 91 |
|
|
2020
Q1 | $213K | Hold |
1,400
| – | – | 0.12% | 109 |
|
|
2019
Q4 | $210K | Buy |
+1,400
| New | +$210K | 0.09% | 136 |
|